Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
CervoMed | CRVO | 16. oct 2024 | 14.05 | +0.29 |
CEVA | CEVA | 16. oct 2024 | 24.60 | -0.61 |
CF Acquisition VII A | CFFS | 16. oct 2024 | 11.11 | -0.18 |
CF Bankshares | CFBK | 16. oct 2024 | 23.85 | +6.00 |
CF Industries | CF | 16. oct 2024 | 84.58 | -0.58 |
CFSB Bancorp | CFSB | 16. oct 2024 | 6.70 | -0.74 |
CG Oncology | CGON | 16. oct 2024 | 37.05 | -0.40 |
CGI | GIB | 16. oct 2024 | 114.71 | -0.62 |
Chain Bridge Bancorp | CBNA | 16. oct 2024 | 21.47 | 0.00 |
Chain Bridge I SPAC A | CBRG | 16. oct 2024 | 11.37 | 0.00 |
Chain Bridge I Units | CBRGU | 16. oct 2024 | 11.26 | 0.00 |
Champion Homes | SKY | 16. oct 2024 | 98.74 | +2.68 |
Champions Oncology | CSBR | 16. oct 2024 | 4.56 | +0.44 |
ChampionX | CHX | 16. oct 2024 | 31.15 | +1.70 |
Chanson International | CHSN | 16. oct 2024 | 12.24 | 0.00 |
ChargePoint | CHPT | 16. oct 2024 | 1.34 | +1.52 |
Charles & Colvard | CTHR | 16. oct 2024 | 1.56 | +1.99 |
Charles River Laboratories International | CRL | 16. oct 2024 | 195.11 | +0.64 |
Charles Schwab | SCHW | 16. oct 2024 | 72.08 | +0.17 |
Chart Industries | GTLS-B | 16. oct 2024 | 51.66 | +1.91 |
Chart Industries | GTLS | 16. oct 2024 | 126.84 | +1.83 |
Charter Communications A | CHTR | 16. oct 2024 | 330.22 | -0.52 |
Chatham Lodging Trust (REIT) A Pref | CLDT-A | 16. oct 2024 | 23.23 | +0.13 |
Chatham Lodging Trust REIT | CLDT | 16. oct 2024 | 8.65 | +1.53 |
Cheche Group | CCG | 16. oct 2024 | 0.80 | +3.58 |
Check Point Software Technolgies | CHKP | 16. oct 2024 | 205.88 | -0.94 |
Check-Cap | CHEK | 16. oct 2024 | 1.49 | +4.93 |
Checkpoint Therapeutics | CKPT | 16. oct 2024 | 2.82 | +6.82 |
Cheer Holding | CHR | 16. oct 2024 | 2.95 | -1.34 |
Cheetah Mobile ADR | CMCM | 16. oct 2024 | 4.00 | +2.30 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.